ArticleJournal of cardiovascular medicine (Hagerstown, Md.)2026
Remote monitoring and outcomes in heart failure: 5-year study.
Article in Journal of cardiovascular medicine (Hagerstown, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimManaging heart failure is particularly challenging for patients with cardiac implantable electronic devices (CIEDs), often suffering from chronic conditions. This study aimed to evaluate the clinical outcomes of patients with implantable cardioverter-defibrillators or cardiac resynchronization therapy defibrillators who were remotely monitored over a 5-year period.
methodsClinical data were sourced from the Electrophysiology Registry of the Cardiology Unit. Survival rates, cardiovascular events (i.e. hospitalization or death), and the risk factors associated with these events were the main focus of the analysis. Univariate survival analyses were performed based on patient characteristics [ischemic disease, age over 75 years, atrial fibrillation, severe chronic kidney disease (CKD)]. Additionally, multivariate survival analysis was conducted using Cox regression.
resultsA total of N = 402 patients were included in the analysis. Over the 5-year follow-up, there were N = 68 deaths and N = 190 cardiovascular events. Kaplan-Meier analysis indicated that ischemic disease, age at least 75 years, atrial fibrillation and severe CKD were statistically significant risk factors for both death and cardiovascular events (log-rank test, P < 0.001). Cox regression analysis confirmed that ischemic disease, age 75 years and older, atrial fibrillation, implantation with a CRT-D device and severe CKD were all associated with a significantly higher risk of cardiovascular events and mortality.
conclusionDespite the proven effectiveness of remote monitoring, the clinical impact of heart failure in patients with CIEDs remains substantial. Continuous enhancements are necessary to facilitate early intervention and improve outcomes for these high-risk groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.